Johnson & Johnson
FDA approves Johnson & Johnson’s nasal spray for depression as standalone treatment
This photo provided by Janssen Global Services shows Spravato nasal spray. Janssen Global Services via AP The Food and Drug Administration on Tuesday approved Johnson & Johnson‘s nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow. The spray, called Spravato, […]
Read More
Earnings playbook: Your guide to this week’s biggest reports, including Netflix
It’s a short week on Wall Street, but there are major earnings reports on deck that could move the stock market. Netflix, Johnson & Johnson and United Airlines are among the 35 S & P 500 companies slated to post their latest quarterly figures. Those come after a week in which big banks reported blockbuster […]
Read More
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Good afternoon from San Francisco! This week, Ashley and I are attending the annual JPMorgan Health Care Conference – the largest gathering of biotech and pharma execs, […]
Read More
Stocks making the biggest moves premarket: Abercrombie & Fitch, Pinterest, Howard Hughes Holdings and more
Check out the companies making headlines before the bell: Quantum stocks — Quantum stocks tumbled on Monday morning, following comments from Mark Zuckerberg echoing Nvidia CEO Jensen Huang that quantum is at least a decade away from being a “useful paradigm.” Zuckerberg made the comments on a Friday episode of the “Joe Rogan Experience.” Shares […]
Read More
Zuckerberg says Biden administration pushed Meta ‘super hard’ to take down vaccine content
Meta CEO Mark Zuckerberg appears at the Meta Connect event in Menlo Park, California, Sept. 25, 2024. David Paul Morris | Bloomberg | Getty Images Meta CEO Mark Zuckerberg told Joe Rogan in a podcast published Friday that his company was pressured by the Biden administration to remove content on side effects of Covid vaccines. […]
Read More
J&J says its lung cancer drug combination keeps people alive longer
Niels Wenstedt | Getty Images Johnson & Johnson on Tuesday said its lung cancer regimen keeps people alive for at least a year longer than AstraZeneca‘s Tagrisso, the go-to drug for a certain type of lung cancer. J&J in a statement said its drugs – Rybrevant and Lazcluze – showed a statistically significant and clinically […]
Read More
High-quality stocks that pay a hefty dividend they are unlikely to cut in 2025, according to UBS
With a bumpy start to 2025, quality stocks that have reliable dividends could become more appealing. The first trading day of the new year marked a volatile session for stocks, with all three major averages finishing yet another session in the red on Thursday after starting off the day with gains. The S & P […]
Read More
These innovative biotech stocks have a good chance of breaking out in 2025
Trends may be shifting in favor of biotech stocks in 2025 after several years of poor performance, but it would still be wise to place your bets carefully on some of the most innovative names. “We’re still optimistic on the outlook for biotech,” said Stacey Sears, senior vice president and portfolio manager at Emerald Advisors, […]
Read More
Apple is among the most overbought stocks on Wall Street. Here are the others
The overall S & P 500 is struggling in December and certain tickers look primed for a further pullback. The broad market index ended Friday down 0.6% for the week, providing a pause from the upward tear equities have been on since President-elect Donald Trump regained the White House last month. The Dow Jones Industrial […]
Read More
SpaceX valuation surges to $350 billion as company buys back stock
SpaceX’s next-generation Starship spacecraft atop its powerful Super Heavy rocket is launched on its sixth test at the company’s Boca Chica launch pad in Brownsville, Texas, on Nov. 19, 2024. Joe Skipper | Reuters The valuation of Elon Musk’s SpaceX hit $350 billion based on a secondary share sale, CNBC confirmed Wednesday. SpaceX, as well as investors, […]
Read More